Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination

Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination

Bibliographic Details
Main Authors: Georg Schett, Bernhard Manger, Thomas Harrer, Filippo Fagni, Arnd Kleyer, Larissa Valor-Méndez, Karin Manger, David Simon, Koray Tascilar, Katja Schmidt, Daniela Bohr, Fabian Hartmann
Format: Article
Language:English
Published: BMJ Publishing Group 2022-05-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/1/e002323.full

Internet

https://rmdopen.bmj.com/content/8/1/e002323.full

Similar Items